Holistic Financial Partners Buys Shares of 3,123 CVS Health Corporation (NYSE:CVS)

Holistic Financial Partners bought a new stake in shares of CVS Health Corporation (NYSE:CVS) in the 1st quarter, Holdings Channel.com reports. The firm bought 3,123 shares of the pharmacy operator’s stock, valued at approximately $212,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of CVS Health in the 4th quarter valued at $839,574,000. Capital World Investors raised its position in shares of CVS Health by 26.6% in the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator’s stock valued at $2,739,927,000 after acquiring an additional 12,819,148 shares during the period. Dodge & Cox grew its stake in shares of CVS Health by 11.2% in the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock valued at $3,147,054,000 after buying an additional 7,075,209 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of CVS Health by 30.1% in the fourth quarter. Invesco Ltd. now owns 18,038,089 shares of the pharmacy operator’s stock worth $809,730,000 after acquiring an additional 4,173,243 shares during the last quarter. Finally, Fairfax Financial Holdings Ltd. Can bought a new position in shares of CVS Health during the 4th quarter worth approximately $121,742,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CVS shares. Mizuho lifted their target price on CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Royal Bank Of Canada boosted their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research report on Monday, May 5th. Morgan Stanley restated an “overweight” rating on shares of CVS Health in a research note on Tuesday, April 15th. Jefferies Financial Group upped their price objective on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Finally, Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $74.82.

Insider Activity at CVS Health

In related news, Director Guy P. Sansone purchased 1,570 shares of the firm’s stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director directly owned 12,007 shares of the company’s stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.22% of the company’s stock.

CVS Health Stock Up 1.2%

CVS opened at $61.80 on Thursday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The company has a market cap of $78.18 billion, a PE ratio of 14.75, a price-to-earnings-growth ratio of 0.87 and a beta of 0.57. The company has a 50-day moving average price of $64.68 and a 200 day moving average price of $63.22. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analysts’ expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.31 earnings per share. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.30%. The ex-dividend date is Tuesday, July 22nd. CVS Health’s dividend payout ratio (DPR) is currently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.